Advertisement
Advertisement

BRTX

BRTX logo

BioRestorative Therapies, Inc. Common Stock (NV)

0.21
USD
Sponsored
-0.02
-8.53%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

0.21

0.00
+2.04%

BioRestorative Therapies, Inc. Common Stock (NV) Profile

About

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company's core programs consist of Disc/Spine Program and Metabolic Program. Disc/Spine Program consists of cell therapy candidate, brtxDISC(TM) is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow. Metabolic Program consists of ThermoStem(R), developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. BioRestorative Therapies, Inc. is based in Melville, New York.

Info & Links

CEO

Lance Alstodt

Headquarters

40 MARCUS DRIVE, SUITE 1
MELVILLE, NY 11747, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.biorestorative.com

Auditor

Marcum LLP

Share holders

343

Employees

14

BioRestorative Therapies, Inc. Common Stock (NV) Statistics

Valuation Measures

Market Capitalization2

5.35M

Enterprise Value

3.84M

Enterprise Value/EBITDA(ttm)

-0.25

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

16.99

Price to Book(mrq)

6.21

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

71.89%

Operating Margin(ttm)

-4039.17%

Profit Margin(ttm)

-16087.14%

Return on Equity(ttm)

-430.91%

Return on Invested Capital(ttm)

-1178.53%

Return on Assets(ttm)

-203.61%

Income Statement

Revenue(ttm)

359.70K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

335.90K

EBITDA(ttm)3

-15.44M

Net Income Available to Common(ttm)

-14.24M

Diluted EPS(ttm)

-1.59

Share Statistics

Beta (5Y Monthly)

0.37

52-Week Change

-88.70%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

25.48M

Dividend Yield

0.00%

Float4

17.63M

% Held by Insiders

30.80%

% Held by Institutions

69.38%

Balance Sheet

Total Cash(mrq)

2.95M

Total Cash Per Share(mrq)

0.12

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.84%

Quick Ratio(mrq)

0.84%

Book Value Per Share(mrq)

0.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.20

Free Cash Flow(ytd)

-10.90M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement